Related Experiment Video
Updated: Aug 13, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
False human hematopoietic cell lines: cross-contaminations and misinterpretations
H G Drexler1, W G Dirks, R A MacLeod
1DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Mascheroder Weg 1 B, D-38124 Braunschweig, Germany.
Abstract:
The risk of adventitious contamination and subsequent overgrowth of cell lines by unrelated cells is a potential and often recurring problem where cells are grown and studied. This problem of intraspecies and interspecies cross-contamination among human cell lines has been recognized for over 25 years; incidences of cell cross-contamination between 17 and 35% have been reported. The most useful methods to detect human cell cross-contamination are DNA fingerprinting and cytogenetic analysis, each complementing the other. Using this combination, we found that in total 14.8% of the human hematopoietic cell lines received either from the original investigator (n = 117 cell lines) or from secondary sources (n = 72 cell lines) were cross-contaminated with another hematopoietic cell line and were thus false cell cultures. Another problem relates to the fact that not every cell line established from a patient with a hematopoietic malignancy is a malignant cell line; unintended immortalization of non-malignant B cells by 'passenger' Epstein-Barr virus (EBV) leads to the establishment of B-lymphoblastoid cell lines (termed EBV+ B-LCLs), an event which is much more frequent than the establishment of a 'true' leukemia-lymphoma-myeloma cell line. These EBV+B-LCLs are most often (albeit not always) unrelated to the malignant clone. The misinterpretation of such EBV+ B-LCLs as true malignant hematopoietic cell lines (particularly in research areas investigating B cell-derived neoplasms such as myeloma) and the indiscriminate use of these cell lines may render some of the results of such studies irrelevant to the pathobiology of the disease concerned. However, a combination of markers commonly allows for an accurate determination of the nature of EBV+ B-LCLs: immunoprofile, cellular morphology, EBV status, and karyotype. In summary, the continuous need for vigilant quality and identity control procedures is emphasized by the high incidences of cross-contaminated cell lines. Most laboratories using cells cultured in vitro maintain multiple cell lines. Such cell lines should be monitored regularly for their identity and specific characteristics in order to prevent invalidation of research work due to incidents of cell line cross-contamination or misinterpretation.
Insights
Human cell line contamination is common, with 14.8% of hematopoietic cell lines being misidentified. Careful quality control using DNA fingerprinting and cytogenetics is crucial to ensure research accuracy.
Area of Science:
- Cell biology
- Genetics
- Cancer research
Background:
- Cell line cross-contamination is a persistent issue in scientific research, affecting 17-35% of studies.
- Human cell lines are susceptible to both intraspecies and interspecies contamination.
- Misidentification of cell lines can lead to irrelevant research findings.
Purpose of the Study:
- To assess the incidence of cross-contamination in human hematopoietic cell lines.
- To identify common sources of cell line misidentification.
- To emphasize the importance of quality control in cell culture.
Main Methods:
- DNA fingerprinting and cytogenetic analysis were used to detect cross-contamination.
- A combination of immunoprofile, cellular morphology, Epstein-Barr virus (EBV) status, and karyotype was used to determine cell line identity.
- 189 human hematopoietic cell lines were analyzed.
Main Results:
- 14.8% of analyzed human hematopoietic cell lines were cross-contaminated.
- Unintended immortalization of non-malignant B cells by EBV (EBV+ B-LCLs) is a frequent source of misidentified cell lines.
- Misinterpretation of EBV+ B-LCLs as malignant cell lines can compromise research on B cell-derived neoplasms.
Conclusions:
- Vigilant quality and identity control procedures are essential due to high incidences of cell line cross-contamination.
- Regular monitoring of cell line identity and characteristics is necessary to prevent invalid research.
- Accurate cell line authentication ensures the reliability of scientific findings.
Related Concept Videos
Lineage Commitment
Regulation of Hematopoietic Stem Cells
Cell Lines

